Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1 1

Status

Completed 3Unknown 1Active not recruiting 1

Sponsor Class

OTHER 457INDUSTRY 205NETWORK 30NIH 26OTHER_GOV 5UNKNOWN 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Sarcoma 1Lymphoid 1Gastrointestinal 1

Conditions

Neoplasm Metastasis 2Stomach Neoplasms 1Sarcoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 48Capecitabine 41Gemcitabine 33apatinib 32Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Nivolumab 17pembrolizumab 16Surgical Procedures, Operative 16Exercise 16Metformin 15S 1 (combination) 14camrelizumab 13Radiation 13Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11Vinorelbine 10Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × durvalumab × Clear all
NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
603 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT03446547 2026-04-14

ASTEROID

Vastra Gotaland Region

Phase 2 Completed
106 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05000710 2024-12-05

CORAL-Lung

Sheba Medical Center

Phase 2 Active not recruiting
29 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT03610061 2024-04-12

RaDD

Austin Health

Phase 1 Completed
34 enrolled
Lymphoid

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse

NCT04893252 2022-11-30

Vactosertib and Durvalumab in Gastric Cancer

National Cancer Center, Korea

Phase 2 Unknown
55 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡